Hip Replacement Market Analysis, Size, Trends | Global | 2018-2024 | MedCore

Hip Replacement Market Analysis, Size, Trends | Global | 2018-2024 | MedCore

0

  • Year: 2018
  • Scope: 2014-2024
  • Region: Australia, Brazil, China, Europe, India, Japan, South Korea, United States
  • Pages: 598
  • Type: MedCore

Industry Trends

Cost-cutting measures at hospitals and surgery centers continue to drive down the ASPs of the hip replacement market. The long-term market growth will be primarily driven by patient demographics, characterized by an ever-growing aging population and an increasing number of younger patients.

Considering the mature nature of the hip arthroplasty market, the development and adoption of new technology is also expected to contribute to its long-term growth. The newest developments in hip arthroplasty include the use of additive manufacturing, or 3D printing, and sensor technology, as well as the adoption of robotics in the form of the robotic-assisted hip arthroplasty procedures. Further information on the emerging trends and the new technologies market can be found in Appendix I of this report.

Despite steady growth in procedure volumes in the United States, growth in the market value of all segments and subsegments of the overall hip replacement market is stymied by the offsetting price cuts throughout the U.S. healthcare system. The fastest-growing segments of the total hip replacement market were represented by implants with ceramic heads and HCPE liners, as well as by cementless devices in the U.S. An increasing acceptance of cementless implants, which allow for a reduction in surgical time compared to cemented alternatives, will be further driven by an overall industrial shift towards outpatient settings, as more hip replacement procedures are expected to be performed in ASCs.

A primary total hip replacement (THR) replaces the entire hip joint. THR implants typically have three components: a stem, a head and an acetabular cup. Partial implants replace only the femoral or acetabular side of the joint. This form of procedure is known as hemiarthroplasty. These devices are colloquially known as hemis within the industry and are often modular components of total implant systems. Resurfacing is an alternative form of implantation to total joint replacement. Rather than removing the entire femoral head, a cap with a short stem is placed onto the bone. This allows for greater preservation of bone stock over a THR and also has the advantage of being easier to revise when the resurfacing implant becomes worn. Revision implants become necessary when original implants of any type become worn over time or through pathology. A conservative estimate of the viability of any implant is approximately 15 years. Revision devices are not significantly different than the original primary total replacements, but the stems may be longer to aid fixation within the femur.

The Only Medical Device Market Research With:

Unit Sales Growth Analysis
Average Selling Prices
Competitor Shares by Segment & Country
 SKU-Level Research Methods
 The Lowest Acquisition Cost

Highly Detailed Segmentation

  • Total Hip Replacement Market
  • Partial Hip Replacement Market
  • Hip Resurfacing Market
  • Hip Replacement Revision Market

hip replacement market segmentation map from latest report by iData Research

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Hip Replacement Market Share Insights

Through the hip replacement device market, Zimmer Biomet is the clear leader, particularly in Europe, where they command nearly one-third of the market themselves. In the United States, Zimmer is closely followed by Depuy Synthes, Stryker, and Smith & Nephew, the other prominent players in the major regions. The market in Europe is significantly more fragmented, with these top companies commanding just over three-quarters of the market, whereas in the United States, these companies make up over 85% of the market.

Although Zimmer Biomet remains a market leader in the large joint device market, their sales in both the knee and hip replacement markets declined slightly in 2017 as a result of supply issues related to production delays from the company’s Warsaw North Campus facility. The company benefited from the issues associated with the use of metal-on-metal hip implant systems, since their product line offers alternatives to these bearing types. Zimmer Biomet’s strong market share was largely attributed to the sales of their Taperloc® Hip System, Arcos® Modular Hip System and G7® Acetabular System, as well as the Continuum™ Acetabular System, which is available in various bearing types.

Throughout this global study, iData’s team of analysts researched nearly 50 companies, the whole list is included below:

 

All Companies Analyzed in this Study

  • Aesculap
  • AK Medical
  • Allegra Orthopaedics
  • Amplitude
  • B. Braun
  • Baimtec Jinghang
  • Biorad Medisys
  • Biotechni
  • Cellumed
  • Consensus Orthopedics
  • Corentec
  • Corin Group
  • Dedienne Sante
  • DePuy Synthes
  • DJO Global
  • Exactech
  • FH Orthopedics
  • Global Orthopaedic Technology
  • Groupe Lepine
  • Gruppo Bioimpianti
  • Implantcast
  • Jiangsu Jinlu Group
  • JRI
  • Kyocera Corporation
  • Lima Corporate
  • LINK
  • Mathys
  • Medacta
  • Microport
  • OMNIlife Science
  • Ortho Development
  • Orthotech
  • Peter Brehm
  • SAMO
  • SeohanCare
  • Sharma Orthopedic
  • Signal Medical Corporation
  • Smith & Nephew
  • StelKast
  • Stryker
  • Symbios
  • Teijin Nakashima Medical
  • United Biomech Japan
  • Weigao Ortho
  • Zimmer Biomet

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled Large Joint Devices Market – MedSuite.







iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link